Lisata Therapeutics, Inc. is a clinical-stage pharmaceutical company, which engages in the discovery, development, and commercialization of innovative therapies for the treatment of solid tumors and other major diseases. Its product, Certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered anti-cancer drugs to target and penetrate tumors. The company was founded in 1980 and is headquartered in Basking Ridge, NJ.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
26
Frequently Asked Questions
What is Market Cap of Lisata Therapeutics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Lisata Therapeutics Inc market cap is $19.18M.
What is the 52-week high for Lisata Therapeutics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Lisata Therapeutics Inc 52 week high is $4.20 as of September 14, 2025.
What is the 52-week low for Lisata Therapeutics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Lisata Therapeutics Inc 52 week low is $1.87 as of September 14, 2025.
What is Lisata Therapeutics Inc stock price today?
Lisata Therapeutics Inc stock price today is $2.19.
What was Lisata Therapeutics Inc stock price yesterday?
Lisata Therapeutics Inc stock price yesterday was $2.24.
What is the PE ratio of Lisata Therapeutics Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Lisata Therapeutics Inc’s P/E ratio is -0.98.
What is the Price-to-Book ratio of Lisata Therapeutics Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Lisata Therapeutics Inc P/B ratio is 0.8984.
What is the 50-day moving average of Lisata Therapeutics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Lisata Therapeutics Inc 50-day moving average is $2.53.
How many employess does Lisata Therapeutics Inc has?